Technology
Ultra Clean Reports Third Quarter 2026 Financial Results
Published
3 days agoon
By
HAYWARD, Calif., Oct. 27, 2026 /PRNewswire/ — Ultra Clean Holdings, Inc. (Nasdaq: UCTT), today reported its financial results for the third quarter ended September 25, 2026.
Highlights for the Third Quarter 2026 were as follows:
Record revenue of $759 million, up 18% compared to Q2 2026 and up 49% compared to Q3 2025.GAAP gross margin of 16.9% and non-GAAP gross margin of 17.3%.GAAP EPS of $0.85 and non-GAAP EPS of $1.15.
“UCT delivered another strong quarter of growth and solid operational performance, as we responded with speed and agility to scale production and meet accelerating customer demand,” said James Xiao, CEO. “We are positioning UCT to capture more value from this next phase of AI-driven industry expansion by co-innovating with our customers, developing more advanced solutions, and executing with focus and discipline. Through UCT 3.0, we are building a more agile and efficient company that is well positioned to anticipate customer needs, accelerate innovation, and translate industry growth into lasting shareholder value.”
Third Quarter 2026 GAAP Financial Results
Total revenue was $759.0 million. Products contributed $681.9 million and Services added $77.1 million. Total gross margin was 16.9%, operating margin was 7.1%, and net income was $39.1 million or $0.85 per diluted share. This compares to total revenue of $644.9 million, gross margin of 16.1%, operating margin of 4.6%, and net income of $8.7 million or $0.19 per diluted share, in the prior quarter.
Third Quarter 2026 Non-GAAP Financial Results
On a non-GAAP basis, gross margin was 17.3%, operating margin was 9.0%, and net income was $53.2 million or $1.15 per diluted share. This compares to gross margin of 16.7%, operating margin of 7.0%, and net income of $32.3 million or $0.70 per diluted share, in the prior quarter.
Fourth Quarter 2026 Outlook
The Company expects revenue in the range of $800 million to $860 million. The Company expects GAAP diluted net income per share to be between $1.02 and $1.26, and non-GAAP diluted net income per share to be between $1.11 and $1.35.
Conference Call
The call will take place at 1:45 p.m. PT and can be accessed by dialing 1-800-836-8184 or 1-646-357-8785. No passcode is required. A replay of the call will be available by dialing 1-888-660-6345 or 1-646-517-4150 and entering the confirmation code 33664#. The Webcast will be available on the Investor Relations section of the Company’s website at http://uct.com/investors/events/.
About Ultra Clean Holdings, Inc.
Ultra Clean Holdings, Inc. is a leading developer and supplier of critical subsystems, components, parts, and ultra-high purity cleaning and analytical services, primarily for the semiconductor industry. Under its Products division, UCT offers its customers an integrated outsourced solution for major subassemblies, improved design-to-delivery cycle times, design for manufacturability, prototyping, and high-precision manufacturing. Under its Services Division, UCT offers its customers tool chamber parts cleaning and coating, as well as micro-contamination analytical services. Ultra Clean is headquartered in Hayward, California. Additional information is available at www.uct.com.
Use of Non-GAAP Measures
In addition to providing results that are determined in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”), management uses non-GAAP gross margin, non-GAAP operating margin and non-GAAP net income to evaluate the Company’s operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analyzing our core business and business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP. Tables presenting reconciliations from GAAP results to non-GAAP results are included at the end of this press release.
The Company defines non-GAAP net income as net loss before amortization of intangible assets, stock-based compensation, restructuring charges, debt refinancing costs, legal-related costs, unrealized loss (gain) on foreign exchange, VAT settlement, and the tax effects of the foregoing adjustments.
A reconciliation of our guidance for non-GAAP net income per diluted share for the subsequent quarter is not available due to fluctuations in the geographic mix of our earnings from quarter to quarter, which impacts our tax rate and cannot be reasonably predicted or determined. As a result, such reconciliation is not available without unreasonable efforts and we are unable to determine the probable significance of the unavailable information.
Safe Harbor Statement
The foregoing information contains, or may be deemed to contain, “forward-looking statements” (as defined in the US Private Securities Litigation Reform Act of 1995) which reflect our current views with respect to future events and financial performance. We use words such as “anticipates,” “projection,” “outlook,” “forecast,” “believes,” “plan,” “expect,” “future,” “intends,” “may,” “will,” “estimates,” “see,” “predicts,” “should” and similar expressions to identify these forward-looking statements. Forward looking statements included in this press release include our expectations about the semiconductor capital equipment market and outlook. All forward-looking statements address matters that involve risks and uncertainties. Accordingly, the Company’s actual results may differ materially from the results predicted or implied by these forward-looking statements. These risks, uncertainties and other factors also include, among others, those identified in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in our annual report on Form 10-K for the year ended December 26, 2025, as filed with the Securities and Exchange Commission. Ultra Clean Holdings, Inc. undertakes no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise unless required by law.
Contact:
Rhonda Bennetto
SVP Investor Relations
rbennetto@uct.com
ULTRA CLEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited; in millions, except per share data)
Three Months Ended
Nine Months Ended
September 25, 2026
September 26, 2025
September 25, 2026
September 26, 2025
Revenues:
Products
$ 681.9
$ 445.0
$ 1,720.3
$ 1,356.9
Services
77.1
65.0
217.3
190.4
Total revenues
759.0
510.0
1,937.6
1,547.3
Cost of revenues:
Products
575.7
380.4
1,465.2
1,163.9
Services
54.9
47.4
155.9
137.8
Total cost of revenues
630.6
427.8
1,621.1
1,301.7
Gross profit
128.4
82.2
316.5
245.6
Operating expenses:
Research and development
8.8
7.8
26.1
23.2
Sales and marketing
15.9
15.1
47.8
45.5
General and administrative
50.0
48.7
148.1
144.1
Impairment of goodwill
—
—
—
151.1
Total operating expenses
74.7
71.6
222.0
363.9
Income (loss) from operations
53.7
10.6
94.5
(118.3)
Interest income
1.4
1.1
3.8
3.0
Interest expense
(1.5)
(9.9)
(9.8)
(29.9)
Other expense, net
(2.5)
(1.2)
(3.2)
(2.5)
Income (loss) before provision for income taxes
51.1
0.6
85.3
(147.7)
Provision for income taxes
10.3
8.7
47.5
23.3
Net income (loss)
40.8
(8.1)
37.8
(171.0)
Less: Net income attributable to noncontrolling interests
1.7
2.8
7.9
6.9
Net income (loss) attributable to UCT
$ 39.1
$ (10.9)
$ 29.9
$ (177.9)
Net income (loss) per share attributable to UCT common stockholders:
Basic
$ 0.86
$ (0.24)
$ 0.66
$ (3.93)
Diluted
$ 0.85
$ (0.24)
$ 0.65
$ (3.93)
Shares used in computing net income (loss) per share:
Basic
45.4
45.4
45.3
45.2
Diluted
46.2
45.4
46.2
45.2
ULTRA CLEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited; in millions)
September 25,
2026
December 26,
2025
ASSETS
Current assets:
Cash and cash equivalents
$ 270,9
$ 311,8
Accounts receivable, net of allowance for credit losses
272,4
208,8
Inventories
723,3
390,9
Prepaid expenses and other current assets
67,6
48,2
Total current assets
1 334,2
959,7
Property, plant and equipment, net
344,4
324,6
Goodwill
114,2
114,2
Intangible assets, net
136,4
156,8
Deferred tax assets, net
4,1
3,5
Operating lease right-of-use assets
156,3
157,2
Other non-current assets
14,8
13,0
Total assets
$ 2 104,4
$ 1 729,0
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt
$ —
$ 9,9
Accounts payable
335,2
194,9
Accrued compensation and related benefits
63,3
51,1
Operating lease liabilities
22,3
20,2
Other current liabilities
57,8
24,6
Total current liabilities
478,6
300,7
Long-term debt
635,1
467,0
Deferred tax liabilities
13,7
13,8
Operating lease liabilities
152,7
156,6
Other liabilities
11,0
6,8
Total liabilities
1 291,1
944,9
Equity:
UCT stockholders’ equity:
Common stock
0,1
0,1
Additional paid-in capital
601,6
578,7
Common shares held in treasury
(88,7)
(48,4)
Retained earnings
219,1
189,2
Accumulated other comprehensive loss
(4,6)
(8,6)
Total UCT stockholders’ equity
727,5
711,0
Noncontrolling interests
85,8
73,1
Total equity
813,3
784,1
Total liabilities and equity
$ 2 104,4
$ 1 729,0
ULTRA CLEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; in millions)
Nine Months Ended
September 25,
2026
September 26,
2025
(In millions)
Cash flows from operating activities:
Net income (loss)
$ 37.8
$ (171.0)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
37.5
35.5
Amortization of intangible assets
20.4
21.2
Stock-based compensation
17.2
14.4
Amortization of debt issuance costs
2.5
2.1
Loss on extinguishment of debt
3.4
—
Loss on disposal of property, plant and equipment
1.2
0.7
Impairment of goodwill
—
151.1
Change in the fair value of financial instruments
—
(0.1)
Deferred income taxes
(0.6)
0.4
Changes in assets and liabilities:
Accounts receivable
(63.6)
41.6
Inventories
(332.4)
(1.2)
Prepaid expenses and other current assets
(16.0)
(6.3)
Other non-current assets
0.0
(1.0)
Accounts payable
131.1
(22.8)
Accrued compensation and related benefits
12.2
(0.6)
Income taxes payable
3.3
(12.1)
Operating lease right-of-use assets and operating lease liabilities
(0.9)
10.2
Other liabilities
30.2
(4.6)
Net cash provided by (used in) operating activities
(116.7)
57.5
Cash flows from investing activities:
Purchases of property, plant and equipment
(45.3)
(40.2)
Proceeds from sale of equipment
0.1
3.2
Net cash used in investing activities
(45.2)
(37.0)
Cash flows from financing activities:
Proceeds from the issuance of common stock under at-the-market offering, net of commissions and fees
34.0
—
At-the-market offering costs for the issuance of common stock
(0.1)
—
Proceeds from the issuance of convertible notes
600.0
—
Borrowings on revolving credit facility
50.0
—
Proceeds from bank borrowings
—
59.3
Extinguishment of bank borrowings
—
(59.3)
Proceeds from issuance of common stock
1.1
1.1
Payment of debt issuance costs
(17.4)
(0.6)
Repurchase of common stock
(40.0)
(3.4)
Payment for capped call transactions
(25.1)
—
Principal payments on bank borrowings
(481.5)
(18.2)
Employees’ taxes paid upon vesting of restricted stock units
(4.3)
(1.1)
Payments of dividends to a joint venture shareholder
(0.1)
(0.1)
Net cash provided by (used in) financing activities
116.6
(22.3)
Effect of exchange rate changes on cash and cash equivalents
4.4
2.0
Net increase (decrease) in cash and cash equivalents
(40.9)
0.2
Cash and cash equivalents at beginning of period
311.8
313.9
Cash and cash equivalents at end of period
$ 270.9
$ 314.1
ULTRA CLEAN HOLDINGS, INC.
REPORTABLE SEGMENTS
GAAP TO NON-GAAP RECONCILIATION
(Unaudited; dollars in millions)
GAAP
Non-GAAP
Three Months Ended
Three Months Ended
September 25, 2026
September 25, 2026
Products
Services
Consolidated
Products
Services
Consolidated
Revenues
$ 681.9
$ 77.1
$ 759.0
$ 681.9
$ 77.1
$ 759.0
Gross profit
$ 106.2
$ 22.2
$ 128.4
$ 108.3
$ 23.2
$ 131.5
Gross margin
15.6 %
28.8 %
16.9 %
15.9 %
30.1 %
17.3 %
Income from operations
$ 46.7
$ 7.0
$ 53.7
$ 58.1
$ 10.5
$ 68.6
Operating margin
6.8 %
9.1 %
7.1 %
8.5 %
13.6 %
9.0 %
Three Months Ended
September 25, 2026
Products
Services
Consolidated
Reconciliation of GAAP Gross profit to Non-GAAP Gross profit (in millions)
Reported gross profit on a GAAP basis
$ 106.2
$ 22.2
$ 128.4
Amortization of intangible assets (1)
1.3
1.0
2.3
Stock-based compensation expense (2)
0.6
—
0.6
Restructuring charges (3)
0.2
—
0.2
Non-GAAP gross profit
$ 108.3
$ 23.2
$ 131.5
Reconciliation of GAAP Gross margin to Non-GAAP Gross margin
Reported gross margin on a GAAP basis
15.6 %
28.8 %
16.9 %
Amortization of intangible assets (1)
0.2 %
1.3 %
0.3 %
Stock-based compensation expense (2)
0.1 %
— %
0.1 %
Restructuring charges (3)
0.0 %
— %
0.0 %
Non-GAAP gross margin
15.9 %
30.1 %
17.3 %
Reconciliation of GAAP Income from operations to Non-GAAP Income from operations (in millions)
Reported income from operations on a GAAP basis
$ 46.7
$ 7.0
$ 53.7
Amortization of intangible assets (1)
3.9
2.9
6.8
Stock-based compensation expense (2)
6.3
0.6
6.9
Restructuring charges (3)
0.6
0.0
0.6
Legal-related costs (4)
0.6
—
0.6
Non-GAAP income from operations
$ 58.1
$ 10.5
$ 68.6
Reconciliation of GAAP Operating margin to Non-GAAP Operating margin
Reported operating margin on a GAAP basis
6.8 %
9.1 %
7.1 %
Amortization of intangible assets (1)
0.6 %
3.8 %
0.8 %
Stock-based compensation expense (2)
0.9 %
0.7 %
0.9 %
Restructuring charges (3)
0.1 %
— %
0.1 %
Legal-related costs (4)
0.1 %
— %
0.1 %
Non-GAAP operating margin
8.5 %
13.6 %
9.0 %
1
Amortization of intangible assets related to the Company’s business acquisitions
2
Represents compensation expense for stock granted to employees and directors
3
Represents costs associated with employee separation, severance, retention, and other expenses related to facility closures
4
Represents estimated costs related to certain legal proceedings and a cybersecurity incident
ULTRA CLEAN HOLDINGS, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP ADJUSTED RESULTS
Three Months Ended
September 25,
2026
September 26,
2025
June 26,
2026
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income (in millions)
Reported net income (loss) attributable to UCT on a GAAP basis
$ 39.1
$ (10.9)
$ 8.7
Amortization of intangible assets (1)
6.8
6.9
6.8
Stock-based compensation expense (2)
6.9
4.6
8.1
Restructuring charges (3)
0.6
7.1
0.7
Debt refinancing costs expensed (4)
—
1.1
0.7
Legal-related costs (5)
0.6
0.2
—
Unrealized loss (gain) on foreign exchange (6)
2.6
(2.4)
(1.9)
VAT settlement (7)
—
(0.2)
—
Income tax effect of non-GAAP adjustments (8)
(3.5)
(4.0)
(2.9)
Income tax effect of valuation allowance (9)
0.1
8.6
12.1
Non-GAAP net income attributable to UCT
$ 53.2
$ 11.0
$ 32.3
Reconciliation of GAAP Income from operations to Non-GAAP Income from operations (in millions)
Reported income from operations on a GAAP basis
$ 53.7
$ 10.6
$ 29.5
Amortization of intangible assets (1)
6.8
6.9
6.8
Stock-based compensation expense (2)
6.9
4.6
8.1
Restructuring charges (3)
0.6
7.1
0.7
Legal-related costs (5)
0.6
0.2
—
VAT settlement (7)
—
(0.2)
—
Non-GAAP income from operations
$ 68.6
$ 29.2
$ 45.1
Reconciliation of GAAP Operating margin to Non-GAAP Operating margin
Reported operating margin on a GAAP basis
7.1 %
2.1 %
4.6 %
Amortization of intangible assets (1)
0.8 %
1.3 %
1.0 %
Stock-based compensation expense (2)
0.9 %
0.9 %
1.3 %
Restructuring charges (3)
0.1 %
1.4 %
0.1 %
Legal-related costs (5)
0.1 %
0.0 %
— %
VAT settlement (7)
— %
0.0 %
— %
Non-GAAP operating margin
9.0 %
5.7 %
7.0 %
Reconciliation of GAAP Gross profit to Non-GAAP Gross profit (in millions)
Reported gross profit on a GAAP basis
$ 128.4
$ 82.2
$ 103.7
Amortization of intangible assets (1)
2.3
2.3
2.3
Stock-based compensation expense (2)
0.6
0.5
1.5
Restructuring charges (3)
0.2
2.1
0.1
VAT settlement (7)
—
(0.2)
—
Non-GAAP gross profit
$ 131.5
$ 86.9
$ 107.6
Reconciliation of GAAP Gross margin to Non-GAAP Gross margin
Reported gross margin on a GAAP basis
16.9 %
16.1 %
16.1 %
Amortization of intangible assets (1)
0.3 %
0.4 %
0.4 %
Stock-based compensation expense (2)
0.1 %
0.1 %
0.2 %
Restructuring charges (3)
0.0 %
0.4 %
0.0 %
VAT settlement (7)
— %
0.0 %
— %
Non-GAAP gross margin
17.3 %
17.0 %
16.7 %
Reconciliation of GAAP Other income (expense), net to Non-GAAP Other income (expense), net (in millions)
Reported Other income (expense), net on a GAAP basis
$ (2.5)
$ (1.2)
$ 0.6
Debt refinancing costs expensed (4)
—
1.1
0.7
Unrealized loss (gain) on foreign exchange (6)
2.6
(2.4)
(1.9)
Non-GAAP Other income (expense), net
$ 0.1
$ (2.5)
$ (0.6)
Reconciliation of GAAP Income (Loss) Per Diluted Share to Non-GAAP Earnings Per Diluted Share
Reported net income (loss) on a GAAP basis
$ 0.85
$ (0.24)
$ 0.19
Amortization of intangible assets (1)
0.15
0.15
0.15
Stock-based compensation expense (2)
0.15
0.10
0.18
Restructuring charges (3)
0.01
0.16
0.01
Debt refinancing costs expensed (4)
—
0.02
0.01
Legal-related costs (5)
0.01
0.00
—
Unrealized loss (gain) on foreign exchange (6)
0.06
(0.05)
(0.04)
VAT settlement (7)
—
0.00
—
Income tax effect of non-GAAP adjustments (8)
(0.08)
(0.09)
(0.06)
Income tax effect of valuation allowance (9)
0.00
0.19
0.26
Impact of dilutive shares
0.00
0.00
0.00
Non-GAAP net earnings
$ 1.15
$ 0.24
$ 0.70
Weighted average number of diluted shares (in millions) on a non-GAAP basis (10)
46.2
45.6
46.0
ULTRA CLEAN HOLDINGS, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP EFFECTIVE INCOME TAX RATE
Three Months Ended
September 25,
2026
September 26,
2025
June 26,
2026
Provision for income taxes on a GAAP basis
$ 10.3
$ 8.7
$ 18.1
Income tax effect of non-GAAP adjustments (8)
3.5
4.0
2.9
Income tax effect of valuation allowance (9)
(0.1)
(8.6)
(12.1)
Non-GAAP provision for income taxes
$ 13.7
$ 4.1
$ 8.9
Income before income taxes on a GAAP basis
$ 51.1
$ 0.6
$ 30.0
Amortization of intangible assets (1)
6.8
6.9
6.8
Stock-based compensation expense (2)
6.9
4.6
8.1
Restructuring charges (3)
0.6
7.1
0.7
Debt refinancing costs expensed (4)
—
1.1
0.7
Legal-related costs (5)
0.6
0.2
—
Unrealized loss (gain) on foreign exchange (6)
2.6
(2.4)
(1.9)
VAT settlement (7)
—
(0.2)
—
Non-GAAP income before income taxes
$ 68.6
$ 17.9
$ 44.4
Effective income tax rate on a GAAP basis
20.2 %
1450.0 %
60.3 %
Non-GAAP effective income tax rate
20.0 %
22.9 %
20.0 %
1 Amortization of intangible assets related to the Company’s business acquisitions
2 Represents compensation expense for stock granted to employees and directors
3 Represents costs associated with employee separation, severance, retention, and other expenses related to facility closures
4 Represents certain third party transaction costs related to the amended credit agreement and the previously capitalized costs of extinguished debt
5 Represents estimated costs related to certain legal proceedings and a cybersecurity incident
6 Represents unrealized foreign exchange gains and losses arising from the remeasurement of monetary assets and liabilities
7 Represents impact of value added tax ruling
8 Tax effect of items (1) through (7) above based on the non-GAAP tax rate
9 The Company’s GAAP tax expense is generally higher than the Company’s non-GAAP tax expense, primarily due to losses in the U.S. with full federal and state valuation allowances. The Company’s non-GAAP tax rate and resulting non-GAAP tax expense considers the tax implications as if there was no federal or state valuation allowance position in effect
10 Non-GAAP diluted weighted-average common shares are adjusted to reflect the dilutive impact of our convertible note based on the capped call cap price instead of the initial conversion price
View original content to download multimedia:https://www.prnewswire.com/news-releases/ultra-clean-reports-third-quarter-2026-financial-results-302921159.html
SOURCE Ultra Clean Holdings, Inc.
You may like
From Nobel Prize Laureates and NASA Astronauts to Music Legends: STARMUS VIII Unites the World’s Greatest Minds in a Historic Celebration of Science, Music and Humanity
Tenerife & La Palma, Canary Islands, Spain | 17–22 October 2026
CANARY ISLANDS, Spain, Oct. 30, 2026 /PRNewswire/ — From the iconic sound of Sir Brian May’s legendary Red Special guitar and the extraordinary voices of Andrea Bocelli and Sarah Brightman to the groundbreaking discoveries of Nobel Prize-winning scientists, from NASA’s Artemis II astronauts preparing for humanity’s return to the Moon to historic tributes to Stephen Hawking and Jane Goodall, STARMUS VIII — The Search for Truth brought together an extraordinary constellation of scientific minds, legendary musicians, explorers and visionary thinkers for six unforgettable days in the Canary Islands.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/starmus-foundation/9430551-en-starmus-viii-the-search-for-truth-festival-2026
Held across Tenerife and La Palma from 17 to 22 October 2026, the eighth edition of STARMUS transformed the islands into a global stage for scientific discovery, artistic excellence and some of the most important conversations shaping humanity’s future.
Founded by astrophysicist Dr. Garik Israelian and legendary Queen guitarist and astrophysicist Sir Brian May, STARMUS once again demonstrated its unique ability to bridge science, music and society, bringing complex scientific ideas to audiences through extraordinary encounters, performances and shared experiences.
This year’s festival marked two defining milestones: the 10th anniversary of the Stephen Hawking Medal for Science Communication and the inauguration of the Jane Goodall Earth Medal, establishing a powerful connection between humanity’s ambition to explore the universe and its responsibility to protect the planet we call home.
Media Contacts:
US: Dan DuPont, dupont0708@gmail.com, +1 202 380 7558
UK/EU: Nicole Ettinger, nicole@ettingerpr.com, +44 7515 394107
Spain: Carlos Esteban, cesteban@llys.global, +34 699 55 2854
View original content:https://www.prnewswire.com/news-releases/starmus-viii–the-search-for-truth-302924867.html
SOURCE Starmus Foundation
Technology
Membrane Chromatography Market worth $0.63 billion by 2031 – Exclusive Report by MarketsandMarkets™
Published
55 seconds agoon
October 30, 2026By
DELRAY BEACH, Fla., Oct. 30, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Membrane Chromatography Market is projected to reach USD 0.63 billion by 2031 from USD 0.37 billion in 2026, at a CAGR of 11.3% during the forecast period.
Browse 417 market data Tables and 51 Figures spread through 343 Pages and in-depth TOC on ‘Membrane Chromatography Market – Global Forecast to 2031’
Membrane Chromatography Market Size & Forecast:
Market Size Available for Years: 2026–20312026 Market Size: USD 0.37 billion2031 Projected Market Size: USD 0.63 billionCAGR (2026–2031): 11.3%
Membrane Chromatography Market Trends & Insights:
By region, North America accounted for the largest share of ~37.4% of the market in 2025.By product, the capsules, cassettes, and cartridges segment is projected to register the highest CAGR of 12.0% in the membrane chromatography market during the forecast period.By technique, the ion exchange membrane chromatography segment accounted for the largest share of 58.1% of the membrane chromatography market in 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196
The membrane chromatography market is expected to grow steadily as pharmaceutical and biotechnology companies increase investments in biologics, biosimilars, vaccines, cell & gene therapies, and other advanced therapeutic modalities. Growing production of monoclonal antibodies, recombinant proteins, viral vectors, plasmid DNA, and mRNA is increasing demand for membrane chromatography products, including capsules, cassettes & cartridges, membrane discs & sheets, syringe filters, filter plates, spin columns, and other consumables & accessories. Rising adoption of single-use downstream processing, flow-through purification, affinity capture, and high-throughput polishing is improving process flexibility, throughput, and manufacturing efficiency. Advances in membrane materials, surface functionalization, and high-capacity affinity membranes are further enhancing selectivity, binding capacity, and purification performance. These factors are supporting adoption across pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and academic & research institutes.
The market is increasingly shifting toward high-throughput, single-use, and application-specific membrane chromatography solutions that can support complex biologics and advanced therapeutic modalities. Although conventional resin-based chromatography remains widely adopted, demand is increasing for advanced membrane formats, improved ligand chemistries, higher binding capacities, and intensified flow-through and bind-elute purification approaches that can reduce processing time and improve downstream productivity. Suppliers are expanding product portfolios and developing specialized membrane chemistries to support monoclonal antibodies, viral vectors, plasmid DNA, mRNA, and other biomolecules with challenging purification requirements. At the same time, manufacturers are addressing challenges related to membrane fouling, scalability, selectivity, pressure handling, and process consistency through advanced membrane materials and optimized purification workflows. The growing outsourcing of bioprocess development and manufacturing further supports specialized membrane chromatography providers that can deliver scalable, high-throughput purification solutions with shorter turnaround times and consistent performance.
The flow-through membrane chromatography segment is expected to register the highest growth rate in the membrane chromatography market during the forecast period.
The membrane chromatography market is segmented by operation mode into flow-through membrane chromatography and bind-elute membrane chromatography. During the forecast period, flow-through membrane chromatography is projected to grow faster, supported by rising demand for high-throughput impurity removal, polishing, and process intensification in biopharmaceutical manufacturing. Flow-through processing enables rapid processing, lower pressure drops, reduced buffer consumption, and easier integration with single-use and continuous downstream workflows. However, bind-elute membrane chromatography remains an important operating mode because it supports selective capture and purification of target biomolecules across biologics and advanced therapy manufacturing applications.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=151487196
North America accounted for the largest regional share of the global membrane chromatography market in 2025.
The membrane chromatography market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America accounted for the largest share of the global market, driven by a well-established pharmaceutical and biotechnology industry, strong biopharmaceutical R&D activity, significant biologics manufacturing capacity, and widespread adoption of advanced downstream purification technologies. The region also benefits from major membrane chromatography product providers, pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and research institutions. Continued development and commercialization of monoclonal antibodies, vaccines, viral vectors, and other advanced therapeutics, along with increasing adoption of single-use and high-throughput purification solutions, further support the region’s leading market position.
Key Players
Leading players in the Membrane Chromatography companies include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), i3 Membrane GmbH (Germany), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and MICROSOLV (US), among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=151487196
Investment & Funding Context
The membrane chromatography market is seeing increased investment as companies and research organizations focus on developing high-capacity membranes, scaling up manufacturing, advancing continuous downstream processing, and commercializing single-use purification technologies.
In June 2026, MembraneWorks, Inc. received USD 350,000 through the North Carolina Biotechnology Center’s Small Business Research Loan program to develop high-capacity nonwoven membrane chromatography devices for biopharmaceutical purification. The funding supports further development and commercialization of membrane-based downstream purification technologies.
In June 2025, a North Carolina State University research team received funding under the Gates Foundation-supported Grand Challenges initiative to develop a low-cost, all-membrane chromatography process to purify the antimalarial monoclonal antibody MAM01. The project focuses on single-use membranes, membrane-coupled ligands, scalable device configurations, integration into single-use cassettes, and development of an affordable, scalable biomanufacturing platform. These developments indicate continued funding toward membrane chromatography commercialization, high-capacity membrane devices, single-use purification, process intensification, and scalable biologics manufacturing.
Revenue Shift Context
The membrane chromatography market is gradually shifting from conventional resin-based chromatography and standalone filtration toward a broader mix of single-use membrane adsorbers, high-capacity affinity membranes, flow-through purification solutions, and application-specific consumables. Traditional products such as capsules, cassettes & cartridges, syringe filters, filter plates, spin columns, and membrane discs & sheets remain important revenue pools; however, customers increasingly seek integrated downstream solutions supporting monoclonal antibodies, viral vectors, plasmid DNA, mRNA, and other advanced therapeutic modalities.
Rising demand for single-use and high-throughput purification is further increasing consumption of specialized membrane formats and functionalized chemistries. At the same time, growing outsourcing by pharmaceutical & biopharmaceutical companies to CROs & CDMOs is expanding revenue opportunities for scalable purification platforms and related consumables. Over the forecast period, revenue growth is therefore expected to increasingly favor recurring membrane consumables, affinity membrane chromatography, advanced membrane materials, and integrated flow-through downstream processing workflows.
Mergers & Acquisitions
Mergers & acquisitions in the membrane chromatography market are increasingly focused on expanding downstream purification capabilities, strengthening membrane and filtration portfolios, and improving access to biopharmaceutical manufacturing customers. Buyers are prioritizing technologies that complement single-use processing, membrane-based separations, and integrated upstream-to-downstream workflows.
MEMBRANE CHROMATOGRAPHY MARKET: MERGERS & ACQUISITIONS, JANUARY 2025–SEPTEMBER 2026
Month & Year
Deal Type
Company
1
Company
2
Description
September 2025
Acquisition
Thermo Fisher Scientific Inc. (US)
Solventum Corporation – Purification & Filtration Business (US)
Thermo Fisher Scientific completed the acquisition of Solventum’s Purification & Filtration business for approximately USD 4.0 billion. The acquired business includes bioprocessing filtration and membrane technologies supporting upstream and downstream biopharmaceutical manufacturing. The portfolio includes Polisher ST Membrane Adsorber, a single-use anion exchange membrane chromatography solution for flow-through polishing and removal of host cell proteins, DNA, viruses, and other impurities. The acquisition strengthens Thermo Fisher’s membrane-based purification and broader downstream bioprocessing capabilities.
Company Revenue Share Details
The top four players collectively account for approximately 73–77% of the global membrane chromatography market, indicating a consolidated landscape. The market comprises a mix of diversified life science companies and specialized membrane chromatography product manufacturers. Leading players include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), i3 Membrane GmbH (Germany), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), MICROSOLV (US), among others. Their portfolio spans membrane adsorbers, capsules, cassettes & cartridges, syringe filters, filter plates, spin columns, membrane discs & sheets, and other consumables, along with ion exchange, affinity, and hydrophobic interaction membrane chromatography solutions. The coexistence of large, diversified companies and specialized membrane technology providers creates significant scope for continued competition and consolidation, particularly as companies expand single-use purification portfolios, high-capacity affinity membrane technologies, advanced membrane materials, and geographic reach.
Browse Adjacent Market: Biotechnology Market Research Reports &Consulting
See More Latest Biotechnology Reports:
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) – Global Forecast to 2031
Chromatography Columns Market by Column Type (Ion Exchange, Size Exclusion, Reverse and Normal Phases, HPLC, Affinity, Chiral), Capacity (1-100 ml, 100-1000 ml, >1 liter), End User (Pharma & Biotech, CRO, CDMO) – Global Forecast to 2031
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/membrane-chromatography-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/membrane-chromatography.asp
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/membrane-chromatography-market-worth-0-63-billion-by-2031—exclusive-report-by-marketsandmarkets-302924841.html
Technology
In HelloNation, Assisted Living Experts Rusty and Kelly Ackerman Explain Why Amenities Matter More Than Families Expect
Published
56 seconds agoon
October 30, 2026By
The article examines how amenities shape daily routines, independence, and social connection in senior living communities.
TRAVERSE CITY, Mich., Oct. 30, 2026 /PRNewswire/ — Why do senior living amenities have a greater impact on daily life than many families initially expect? HelloNation has released an article that explains how these features influence comfort, independence, and social connection in meaningful ways.
The article features insights from Assisted Living Experts Rusty and Kelly Ackerman of French Manor Assisted Living in Traverse City, Michigan, and highlights how senior living amenities play a central role in shaping everyday experiences within a community.
The HelloNation article explains that while families often focus on apartments and care services, senior living amenities are deeply connected to how residents spend their time. These amenities are not simply added features but part of the daily routine that supports both independence and engagement.
Dining options are one of the most impactful elements discussed. The article notes that meals are a daily experience that influence routine, health, and social connection. Asking about variety and flexibility helps families understand how dining options support both independence and comfort over time.
The article also explains that flexible dining options allow residents to make choices about when and what they eat. This ability to choose supports independence and reinforces a sense of control, which is especially important during transitions into a new living environment.
Activity spaces are another essential component of senior living amenities. The article describes how these spaces support hobbies, group events, and informal gatherings. Well-used activity spaces encourage residents to remain engaged and provide natural opportunities for social connection throughout the day.
In addition, activity spaces help foster spontaneous interaction. Residents may gather for conversation or shared interests, which strengthens community bonds. The article emphasizes that accessible and active spaces contribute directly to both engagement and independence.
Outdoor areas also play a significant role in daily life. The article explains that access to outdoor areas allows residents to enjoy fresh air, walk safely, and experience a change of environment. These outdoor areas help create a balanced routine and support emotional well-being.
The article further notes that time spent outdoors can improve mood and reduce stress. When outdoor areas are designed with safety and accessibility in mind, they support both independence and overall comfort.
Wellness programs are another key aspect of senior living amenities. The article describes how these programs provide structure through fitness and health-focused activities. Consistent wellness programs help residents maintain strength, confidence, and long-term well-being.
Wellness programs also encourage social connection by bringing residents together in shared activities. Participation in these programs helps build relationships while supporting physical health, reinforcing a sense of purpose within the community.
The article highlights that social connection is often shaped by how effectively senior living amenities are used. Dining options, activity spaces, outdoor areas, and wellness programs all create opportunities for interaction that help residents feel connected rather than isolated.
Senior living amenities also support independence in practical ways. Easy access to these features allows residents to make choices throughout the day, reinforcing confidence and autonomy over time.
Overall, the HelloNation article emphasizes that senior living amenities play a direct role in shaping comfort, independence, and social connection. Families are encouraged to look beyond appearance and ask how these amenities function on a daily basis to better understand the full living experience.
For families evaluating options, the article provides a clear perspective on how senior living amenities contribute to quality of life in ways that may not be immediately visible during a tour.
Why Amenities Matter More Than Families Expect features insights from Rusty and Kelly Ackerman, Assisted Living Experts of Traverse City, Michigan, in HelloNation.
About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.
View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-assisted-living-experts-rusty-and-kelly-ackerman-explain-why-amenities-matter-more-than-families-expect-302925027.html
SOURCE HelloNation
STARMUS VIII — THE SEARCH FOR TRUTH
Membrane Chromatography Market worth $0.63 billion by 2031 – Exclusive Report by MarketsandMarkets™
In HelloNation, Assisted Living Experts Rusty and Kelly Ackerman Explain Why Amenities Matter More Than Families Expect
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Near Videos4 days agoNEAR is building a universal liquidity layer.
-
Technology5 days agoTin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf
-
Technology4 days agoTrueLoyal® Appoints Erica Thompson as Head of Loyalty
-
Technology5 days agoOASE+ and Elsevier Agree Next-Phase Read and Publish Agreement to Expand Open Access Publishing in Japan
-
Coin Market3 days agoBitcoin ETFs claw back $110M after $774M exit
-
Technology3 days agoSPS Releases New Report on Turning Workplace Data and AI into a Competitive Advantage
-
Technology5 days agoFFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia’s Investor Weekly Report to October 26
-
Technology5 days agouSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart
